Fremont, CA, United States of America

Martin Costello

USPTO Granted Patents = 10 



Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2005-2022

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Martin Costello: Innovator in Pharmaceutical Technology

Introduction

Martin Costello is a prominent inventor based in Fremont, CA, known for his significant contributions to pharmaceutical technology. With a total of 10 patents to his name, he has made remarkable advancements in the field of drug delivery systems.

Latest Patents

One of Martin's latest inventions is the rapidly disintegrating gelatinous coated tablet. This innovative dosage form features two end regions coated with gelatinous materials and an exposed circumferential band. Openings are provided in the exposed band to reveal the core material. The invention also encompasses methods for manufacturing such gelatinous coated dosage forms, enhancing the efficiency and effectiveness of drug delivery.

Career Highlights

Throughout his career, Martin has worked with notable companies, including Johnson & Johnson Consumer Inc. and McNeil-PPC, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the pharmaceutical industry.

Collaborations

Martin has collaborated with esteemed colleagues such as Roger A. Rinker and Nicholas J. Casale. These partnerships have fostered a creative environment that has led to the development of cutting-edge technologies in drug formulation.

Conclusion

Martin Costello's work in the field of pharmaceutical technology exemplifies the spirit of innovation. His contributions, particularly in the area of rapidly disintegrating gelatinous coated tablets, have the potential to significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…